CASI Pharmaceuticals Announces $48.5 Million Private Placement

ROCKVILLE, Md., Sept. 14, 2018 -- (Healthcare Sales & Marketing Network) -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innova... Biopharmaceuticals, Venture Capital CASI Pharmaceuticals, Spectrum Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news